Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Vikram MathewsMammen Chandy

Abstract

PURPOSE We previously reported our results with a single-agent arsenic trioxide (ATO) -based regimen in newly diagnosed cases of acute promyelocytic leukemia (APL). The concern remained about the long-term outcome of this well-tolerated regimen. We report our long-term follow-up data on the same cohort. PATIENTS AND METHODS From January 1998 to December 2004, 72 patients with PML/RARalpha+ APL were enrolled. All patients were treated with a single-agent ATO regimen. Results Overall 62 (86.1%) achieved a hematologic remission (complete remission). After the initial report, an additional seven patients have relapsed for a total of 13 relapses. There were no additional toxicities to report on follow-up. At a median follow-up 60 months, the 5-year Kaplan-Meier estimate (+/- SE) of event-free survival, disease-free survival, and overall survival (OS) was 69% +/- 5.5%, 80% +/- 5.2%, and 74.2% +/- 5.2%, respectively. The OS in the good risk group as defined by us remains 100% over this period. CONCLUSION Single-agent ATO as used in this study in the management of newly diagnosed cases of APL is safe and is associated with durable responses. Results in the low-risk group are comparable to that reported with conventional therapy while a...Continue Reading

References

Aug 25, 1992·Annals of Internal Medicine·S R FrankelR P Warrell
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·C F SkibolaG Morgan
Sep 18, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L SoignetR P Warrell
Nov 25, 2003·Hematology·Bob LöwenbergMartin S Tallman
Oct 18, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GhavamzadehN Aghdami
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farhad RavandiHagop Kantarjian
Feb 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jiong HuZhu Chen
Oct 3, 2009·Blood·Martin S Tallman, Jessica K Altman
Oct 14, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rajasekar ThirugnanamVikram Mathews

❮ Previous
Next ❯

Citations

Mar 16, 2013·Annals of Hematology·Athena KritharisDaniel R Budman
Feb 26, 2013·Apoptosis : an International Journal on Programmed Cell Death·Julian BertrandDavid Yannick Leger
Jan 17, 2013·Current Treatment Options in Oncology·Harry J Iland, John F Seymour
Nov 11, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Seyed H GhaffariKamran Alimoghaddam
Oct 24, 2013·Inorganic Chemistry·Elden P SwindellThomas V O'Halloran
Oct 23, 2010·Nature Reviews. Cancer·Hugues de Thé, Zhu Chen
Apr 2, 2011·Haematologica·Farhad Ravandi
Jun 8, 2014·Best Practice & Research. Clinical Haematology·Matthew A KutnyJames H Feusner
Jun 8, 2014·Best Practice & Research. Clinical Haematology·Harry J IlandJohn F Seymour
Jun 19, 2014·International Journal of Hematology·Junmin LiZhenyi Wang
Sep 18, 2014·The New England Journal of Medicine·Jacqueline Lehmann-CheHugues de Thé
Sep 27, 2014·Blood·Adeline Vitaliano-PrunierHugues de Thé
Dec 18, 2013·The Journal of Experimental Medicine·Guilherme Augusto Dos SantosPier Paolo Pandolfi
Jul 11, 2012·The Journal of Cell Biology·Hugues de ThéValérie Lallemand-Breitenbach
Aug 12, 2014·Blood Reviews·Justin M Watts, Martin S Tallman
May 5, 2012·Biochimica Et Biophysica Acta·Inês A BarbosaPaulo J Oliveira
Feb 22, 2012·Current Opinion in Chemical Biology·Jian-Xiang LiuZhu Chen
Nov 8, 2011·Trends in Molecular Medicine·Valerie Lallemand-BreitenbachHugues de Thé
Nov 19, 2011·Hematology/oncology Clinics of North America·Muhamed BaljevicMartin S Tallman
Dec 22, 2015·British Journal of Haematology·Francesco Lo-CocoMassimo Breccia
Sep 19, 2015·The Lancet Oncology·Farhad Ravandi, Hagop Kantarjian
Jul 28, 2011·Cancer Science·Tomohiko KamimuraKoichi Akashi
Sep 13, 2012·British Journal of Haematology·Jeffrey E Rubnitz, Hiroto Inaba
Jun 21, 2012·IUBMB Life·Sai-Juan Chen, Guang-Biao Zhou
Aug 19, 2014·International Journal of Cancer. Journal International Du Cancer·Julien Ablain, Hugues de Thé
Mar 19, 2014·Journal of Internal Medicine·K L Rice, H de Thé
Nov 30, 2013·Journal of Cellular Biochemistry·Guoxiang JinHui-Kuan Lin
Jan 21, 2015·European Journal of Haematology·Frank FirkinWai Khoon Ho
May 14, 2014·Journal of Cellular Biochemistry·Ali KhaleghianArdeshir Ghavamzadeh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.